SCHEMBL20154098

SCHEMBL20154098

CC(C)(C)OC(=O)N1CCN(c2nc(-c3scnc3Cl)[nH]c(=O)c2Cl)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 2/20 0.40
POLB P06746 1/20 0.40
GBA1 P04062 2/20 0.40
CKS1B P61024 2/20 0.38
SKP1 P63208 2/20 0.38
SKP2 Q13309 2/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
MET P08581 1/20 0.37
MAP4K4 O95819 1/20 0.37
GRIA1 P42261 1/20 0.36
GPR119 Q8TDV5 1/20 0.36
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20143003 0.90 POLB (0.34) KITPOLBGBA1CKS1BSKP1
SCHEMBL20154093 0.90 POLB (0.34) KITPOLBGBA1CKS1BSKP1
SCHEMBL20154097 0.86 GPR119 (0.39) POLBGPR119
SCHEMBL20154258 0.83 POLB (0.33) POLBCNR1METGPR119
SCHEMBL20138947 0.83 POLB (0.33) POLBCNR1METGPR119
SCHEMBL20154091 0.83 POLB (0.33) POLBGBA1CNR1GPR119
SCHEMBL23369067 0.83 GBA1 (0.47) KITPOLBGBA1CKS1BSKP1
SCHEMBL20138775 0.82 KIT (0.33) KITPOLBGBA1CKS1BSKP1
SCHEMBL19995367 0.79 KIT (0.45) KITPOLBGBA1CKS1BSKP1
SCHEMBL20139189 0.75 GBA1 (0.38) POLBGBA1CKS1BSKP1SKP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538523-B1 PYRIMIDINONE DERIVATIVES AS CDC7 INHIBITORS CANCER RESEARCH TECH LTD (GB) 2021-05-19 EP disclosed
WO-2018087527-A1 PYRIMIDINONE DERIVATIVES AS CDC7 INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2018-05-17 WO disclosed